Efficacy and Safety of Basal Insulin Combined with GLP-1 Receptors Agonists versus Intensified Conventional Insulin Regimens in Type 2 Diabetes: A Meta Analysis of Randomized Controlled Trials
Background / Aim: In Type 2 diabetes, Multiple Daily Injection (MDI) is effective but associated with hypoglycemia, weight gain, and poor adherence. Despite the growing endorsement of basal insulin plus GLP-1 receptor Agonist (GLP-1RA) as a streamlined therapeutic step-down, a pooled synthesis that encompasses every pu...